Seeking Alpha
08 Jun 2026, 21:49 UTC · 1h ago
Medtronic: A Dividend Aristocrat At A Steal Now
Top 2 movers · tap to explore
Seeking Alpha
08 Jun 2026, 21:49 UTC · 1h ago
Top 2 movers · tap to explore
Story key points
4 claims · impact-rated
Medtronic achieved its highest annual revenue growth in 10 years during Q4 2026. — A decade-high growth rate suggests a significant turnaround in fundamental performance and scale.
+0.60Medtronic beat analyst consensus for both revenue and non-GAAP EPS in Q4 2026. — Earnings and revenue beats typically drive short-term positive price action and investor confidence.
+0.40Dividend growth for Medtronic has the potential to reaccelerate within the next 12 to 24 months. — Increased dividend growth is a primary catalyst for Dividend Aristocrat investors and income-focused funds.
+0.30Medtronic maintains an A S&P credit rating with a stable outlook. — A stable, high-grade credit rating lowers financial risk but is generally priced in for a large-cap firm.
Continue reading
6 related stories
Ticker attribution
Model heads
The company beat consensus for revenue and EPS, achieved 10-year high annual revenue growth, and has a stable credit rating.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
5 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
Zacks Investment Research
50m ago
